Procter & Gamble earnings top estimates, but shrinking demand weighs on sales

Procter & Gamble earnings top estimates, but shrinking demand weighs on sales


In this photo illustration, the Procter and Gamble logo is seen on a package of Pepto Bismol on June 05, 2025 in San Anselmo, California.

Justin Sullivan | Getty Images

Procter & Gamble on Thursday reported mixed quarterly results as demand for its Gillette razors and Pampers diapers fell.

The company also tweaked its earnings outlook for fiscal 2026. P&G now expects net earnings per share growth in the range of 1% to 6%, down from its prior forecast of 3% to 9%. The company attributed the change to higher restructuring charges. It reiterated its outlook for sales growth.

“We’ve now completed what we fully expect will be the softest quarter of the fiscal year,” CFO Andre Schulten said on a call with reporters on Thursday.

Shares of the company fell about 1% in premarket trading.

Here’s what P&G reported compared with what Wall Street was expecting, based on a survey of analysts by LSEG:

  • Earnings per share: $1.88 adjusted vs. $1.86 expected
  • Revenue: $22.21 billion vs. $22.28 billion expected

P&G reported fiscal second-quarter net income attributable to the company of $4.32 billion, or $1.78 per share, down from $4.63 billion, or $1.88 per share, a year earlier.

Excluding items such as restructuring costs, the company earned $1.88 per share.

Net sales rose 1% to $22.21 billion. Organic sales, which strips out foreign currency, acquisitions and divestitures, were flat for the quarter.

P&G’s volume fell 1%, as three out of its five product categories reported shrinking volume. The metric excludes pricing, which makes it a more accurate reflection of demand than sales. Like many consumer companies, P&G has seen demand for some of its products fall as inflation-weary consumers hunt for deals, particularly in the U.S., its biggest market.

“People have not stopped washing their hair, they still buy diapers, they do their laundry — albeit at a little bit slower pace, so the market growth has certainly slowed over the last 18 to 24 months,” Schulten said.

The company’s baby, feminine and family care segment saw the steepest decline in demand, with volume falling 5% in the quarter. The company said demand for its family care products, which includes Bounty paper towels, Puffs tissues and Charmin toilet paper, fell the most as it faced tough comparisons to the year-ago period, when retailers and consumers stocked up ahead of expected port strikes.

P&G’s grooming business, which includes Gillette and Venus razors, reported a 2% drop in volume.

The company’s health-care segment saw volume fall 1% in the quarter. The division includes Oral-B, Vicks and Pepto-Bismol.

P&G’s fabric and home care business, which includes brands like Febreze and Tide, reported that volume was unchanged from the year-ago period.

The company’s beauty segment was the only division to report volume growth. It saw volume rise 3%, fueled by stronger demand for its hair care products.

In the second half of the fiscal year, P&G is anticipating stronger sales, fueled by upcoming innovation, according to Schulten. For fiscal 2026, the company expects sales growth between 1% and 5%.



Source

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push
Business

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push

U.S. Senator Elizabeth Warren (D-MA) and Director of the United States Office of Management and Budget, Russell Vought. Kevin Mohatt | Kevin Lamarque | | Reuters Sen. Elizabeth Warren on Friday accused the acting head of the Consumer Financial Protection Bureau of undermining President Donald Trump’s stated push to make credit cards more affordable, according […]

Read More
Why a niche category of CRE lending is suddenly seeing record deals
Business

Why a niche category of CRE lending is suddenly seeing record deals

Wepro | Moment | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight […]

Read More
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
Business

What obesity drugmakers see next in the market: More pills, easier access and drug combinations

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | Bloomberg | Getty Images The future of the booming obesity drug market won’t hinge on drugs that deliver greater weight loss alone.  Top executives from drugmakers big and small told CNBC that the next phase […]

Read More